Treatment of Parkinson's disease with amantadine and levodopa. A one-year study.

[1]  R. Godwin-Austen,et al.  Effects of L-dopa in Parkinson's disease. , 1969, Lancet.

[2]  G. Ashcroft,et al.  Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain. , 1970, Brain : a journal of neurology.

[3]  R. Young,et al.  Amantadine in the treatment of Parkinson's disease. , 1969, JAMA.

[4]  J. Turner.  Third Symposium on Parkinson's Disease , 1970 .

[5]  V. Dallos,et al.  Use of Amantadine in Parkinson's Disease. Results of a Double-blind Trial , 1970, British medical journal.

[6]  J. Pearce,et al.  Amantadine in Parkinsonism. , 1970, Lancet.

[7]  V. G. Vernier,et al.  The toxicologic and pharmacologic properties of amantadine hydrochloride. , 1969, Toxicology and applied pharmacology.

[8]  R. Duvoisin,et al.  Treatment of parkinsonism with levodopa. , 1969, Archives of neurology.

[9]  R. Getz.  Symmetrel in Parkinson' disease. , 1970, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[10]  D. Calne,et al.  L-Dopa and Parkinsonism , 1970, Nature.

[11]  R. Knill-Jones,et al.  Amantadine dosage in treatment of Parkinson's disease. , 1970, Lancet.

[12]  J. Korf,et al.  Fluorimetric determination of 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluid. , 1969, Clinica chimica acta; international journal of clinical chemistry.

[13]  D. Laurence,et al.  Amantadine in parkinsonism. , 1970, Lancet.

[14]  C. Shealy,et al.  Livedo reticularis in patients with parkinsonism receiving amantadine. , 1970, Journal of the American Medical Association (JAMA).

[15]  T. Svensson,et al.  Potentiation by amantadine hydrochloride of L‐dopa‐induced effects in mice , 1970, The Journal of pharmacy and pharmacology.

[16]  R. Knill-Jones,et al.  Controlled trial of amantadine hydrochloride in Parkinson's disease. , 1970, Lancet.

[17]  V. G. Vernier,et al.  Amantadine-Dopamine Interaction: Possible Mode of Action in Parkinsonism , 1970, Science.

[18]  R. Godwin-Austen,et al.  The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa. , 1970, Journal of neurology, neurosurgery, and psychiatry.